Picard Medical, Inc.
$0.9
▼
-9.43%
2026-04-21 08:53:01
www.picardmedical.com
ASE: PMI
Explore Picard Medical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$69.69 M
Current Price
$0.9
52W High / Low
$13.68 / $0.9
Stock P/E
—
Book Value
$0.05
Dividend Yield
—
ROCE
-344.07%
ROE
270.74%
Face Value
—
EPS
$-0.75
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
75
Beta
—
Debt / Equity
184.09
Current Ratio
1.11
Quick Ratio
0.72
Forward P/E
—
Price / Sales
14.36
Enterprise Value
$70.47 M
EV / EBITDA
-5.38
EV / Revenue
14.27
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
Cons
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Cerus Corporation | $2.05 | — | $397.8 M | — | -7.17% | -25.66% | $2.96 / $1.15 | $0.33 |
| 2. | Smith & Nephew plc | $32.71 | 22.84 | $14.01 B | 2.29% | 9.67% | 11.84% | $1,441.5 / $960.8 | $6.22 |
| 3. | Bio-Rad Laboratories, Inc. | NOT FOUND | — | — | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 4. | DexCom, Inc. | $63.4 | 30.77 | $24.57 B | — | 21.72% | 34.5% | $89.98 / $54.11 | $7.14 |
| 5. | Spectral AI, Inc. | $1.89 | — | $60.15 M | — | -1104.36% | 116.67% | $3.21 / $1.13 | $-0.19 |
| 6. | Tactile Systems Technology, Inc. | $25.52 | 30.42 | $580.59 M | — | 12.57% | 8.77% | $37.77 / $8.61 | $9.76 |
| 7. | Xtant Medical Holdings, Inc. | $0.5 | 15.1 | $75.1 M | — | 11.26% | 10.59% | $0.95 / $0.39 | $0.36 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 1.01 M | 1.19 M | 2.13 M | 0.62 M | 0.84 M | — |
| Operating Profit | -3 M | -3.49 M | -3.52 M | -3.25 M | -3.57 M | — |
| Net Profit | -4.29 M | -10.43 M | -6.72 M | -5.56 M | -8.84 M | — |
| EPS in Rs | -0.06 | -0.14 | -0.09 | -0.07 | -0.12 | -0.1 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 4.94 M | 4.39 M | 5.04 M | 4.11 M |
| Operating Profit | -13.26 M | -13.71 M | -15.5 M | -11.07 M |
| Net Profit | -27 M | -21.05 M | -15.57 M | -11.17 M |
| EPS in Rs | -0.36 | -0.28 | -0.21 | -0.15 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 22.55 M | 12.11 M | 11.37 M | 15.44 M |
| Total Liabilities | 18.76 M | 35.84 M | 14.93 M | 4.07 M |
| Equity | 3.79 M | -23.74 M | -3.55 M | 11.37 M |
| Current Assets | 20.73 M | 9.79 M | 8.76 M | 12.12 M |
| Current Liabilities | 18.7 M | 35.33 M | 9.21 M | 3 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -15.67 M | -11.87 M | -10.63 M | -10.72 M |
| Investing CF | 0 M | 0 M | -0.01 M | -0.04 M |
| Financing CF | 27.08 M | 11.74 M | 10.84 M | 5.52 M |
| Free CF | -15.67 M | -11.87 M | -10.64 M | -10.75 M |
| Capex | — | — | -0.01 M | -0.03 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 12.5% | -12.93% | 22.61% | — |
| Earnings Growth % | -28.25% | -35.24% | -39.41% | — |
| Profit Margin % | -546.6% | -479.5% | -308.72% | -271.53% |
| Operating Margin % | -268.36% | -312.28% | -307.4% | -269.07% |
| Gross Margin % | -4.13% | -2.55% | -45.83% | -121.27% |
| EBITDA Margin % | -426.36% | -397.63% | -294.39% | -257.89% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.